Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive Officer, will be presenting at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17, 2021. The presentation details are as follows:
Date: Thursday, June 17, 2021
Time: On demand, beginning at 7:00 AM ET
Webcast: https://journey.ct.events/view/1658d21a-8a59-45ff-939e-0a87d5eab8d9\
The presentation will be webcast on-demand and available for 90 days thereafter using the link provided above.
Mr. Drysdale will also be participating in a panel discussion at 9:00AM ET: Disruptive Psychopharmacology – An Introduction to Psychedelics and the Coming Revolution in Psychiatry.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybsercurity, go to AI-Techpark.com.
